About us

At KNOWLEDGESHIFT, LLC, we are united by a common mission: to deliver innovative medicines that provide a brighter future for people living with neurological and psychiatric disorders. This purpose has driven our scientific curiosity and innovation in ion channel science, and it is enabling us to build a world-class, fully integrated company capable of turning scientific breakthroughs into life-changing medicines. The progress we’ve made since our founding fuels our optimism for the transformative potential of our pipeline to help patients who have been underserved for too long. From our science to our community partnerships, we are committed to making a meaningful impact and reshaping treatment paradigms.

A neuroscience-focused biopharmaceutical company dedicated to delivering life-changing therapeutics for people in need

Contact Us

Commitment to Patients

Patients are at the heart of everything we do. From trial design to post-market support, we engage patients and caregivers to ensure therapies address real-world needs.

Contact Us

Our story

KNOWLEDGESHIFT, LLC was founded in 2012 with a focus on discovering new genetic targets to treat human disease. Soon, we became inspired by the opportunity to translate our genetic insights into life-changing medicines, prompting us to establish our own drug discovery and clinical development capabilities and pursue collaborations with multiple premier biopharmaceutical companies. One of our early areas of focus was the sodium channel Nav1.7, which launched our decades-long scientific commitment to ion channel drug discovery, particularly those expressed in the central and peripheral nervous system.



Contact Us